[Latest] Global Dry Eye Syndrome Treatment Market Size/Share Worth USD 12,281.4 Million by 2033 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
11 déc. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Dry Eye Syndrome Treatment Market Size, Trends and Insights By Type (Evaporative...
Global Immunomodulator Market Projected to Nearly Double, Reaching $477.55 Billion by 2034 - Evolution of Immunomodulatory Treatments for Cancer Creating Lucrative Opportunities for Oncology Applications
27 juin 2024 09h43 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Immunomodulator Market" report has been added to ResearchAndMarkets.com's offering.In a significant development for the healthcare industry,...
Liposomal Cyclosporine A Emerging Drug Insights and Market Forecasts, 2017-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
22 nov. 2023 09h08 HE
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
Therapeutic Drug Monitoring Assay Market to Hit US$ 542 Mn by 2031, Bolstered by an 11.0% CAGR: TMR Report
20 juil. 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 20, 2023 (GLOBE NEWSWIRE) -- The global therapeutic drug monitoring assay market was valued at US$ 198.0 Mn in 2021 and is projected to expand at a CAGR of...
Dry Eye Syndrome Treatment Market Worth US$10.2 Billion by 2033 — Exclusive Report by Persistence Market Research
20 avr. 2023 11h35 HE
|
Persistence Market Research
New York, April 20, 2023 (GLOBE NEWSWIRE) -- The Dry Eye Syndrome Treatment Market is expected to generate US$ 4.8 billion in revenue globally in 2022, and is projected to grow at a CAGR of 7.1% to...
Dry Eye Syndrome Treatment Market to Surpass US$ 24,449.7 Million by 2030, Says Coherent Market Insights (CMI)
10 févr. 2023 08h40 HE
|
CMI
Burlingame, Feb. 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global dry eye syndrome treatment market is estimated to be valued at US$ 7,245.3 million in 2022 and is...
2022 TYSABRI (Natalizumab) Report: A Recombinant Humanized IgG4 Monoclonal Antibody Produced in Murine Myeloma Cells - Drug Insight and Market Forecasts to 2032
22 déc. 2022 06h03 HE
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "TYSABRI (Natalizumab), Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."TYSABRI (Natalizumab),...
The Worldwide Organ Transplantation Industry is Expected to Reach $22.1 Billion by 2026
18 févr. 2022 08h14 HE
|
Research and Markets
Dublin, Feb. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplantation Market (2021-2026) by Treatment, Organ, Product, Transplant, End User, Geography, Competitive Analysis and the Impact of...
ImprimisRx’s Patented Klarity-C® 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometrists
18 juin 2020 07h30 HE
|
Harrow Health, Inc.
SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...